Lamotrigine Titration Protocol

Standard Titration Schedule

The American Academy of Neurology recommends starting lamotrigine at 25 mg once daily for 14 days, then increasing to 50 mg once daily for another 14 days, with careful monitoring for rash, particularly in non-compliant patients with substance abuse history and seizures 1
The standard titration schedule involves increasing the dose by 50 mg every 1-2 weeks as tolerated, targeting maintenance doses of 100-300 mg/day for seizure control, with a minimum of 6-8 weeks to reach therapeutic effect 1

The American College of Emergency Physicians recommends that if lamotrigine is discontinued for more than 5 days, the entire titration schedule must be restarted from 25 mg daily to minimize the risk of serious rash 2
The use of extended-release formulation and once-daily dosing can simplify dosing and improve adherence in non-compliant patients 1
Clear written instructions about the restart protocol and close follow-up during the first 8 weeks can help mitigate the risks associated with non-compliance 2

Patients with substance abuse history may require slower titration and lower maintenance doses due to potential hepatic impairment, and should be monitored for polypharmacy concerns and poor medication adherence patterns 1
The American Academy of Neurology recommends checking for interactions with antiretrovirals or other medications in patients with substance abuse history 1

The American College of Clinical Pharmacology recommends a 50% dose reduction of the standard titration schedule when lamotrigine is used with valproic acid, due to increased half-life and risk of rash 1
When used with enzyme-inducing medications, lamotrigine may require more rapid titration to higher maintenance doses, but still starting with 25 mg daily 3, 1

Baseline laboratory tests, including complete blood count, liver function tests, and renal function tests, should be performed before initiation of lamotrigine 1
Weekly assessment for rash, particularly during weeks 2-8, and monitoring for CNS side effects, such as dizziness, ataxia, and somnolence, are recommended during the titration period 1

The American Academy of Neurology recommends never accelerating titration beyond 2-week intervals, even if the patient is seizure-free, as this dramatically increases rash risk 1
Restarting at a previous dose if the patient has been off medication for more than 5 days is not recommended, and the entire titration schedule should be restarted from 25 mg daily 2
Combining lamotrigine with valproic acid without dose adjustment should be avoided, as this increases lamotrigine levels 2-fold and prolongs half-life 1
For women on hormonal contraceptives, lamotrigine levels may decrease by 50%, requiring dose adjustments and level monitoring 1

The American Academy of Emergency Medicine recommends that lamotrigine should never be loaded in the emergency department unless the patient has been on it for >6 months without rash history, has been off <5 days, and requires a single 6.5 mg/kg oral load 4

For patients who have been off lamotrigine for more than 5 days, the entire titration regimen must be restarted from a low initial dose (≈ 25 mg daily) and progressed over the usual 6‑week schedule to minimize the risk of serious rash. 5

A single loading dose of approximately 6.5 mg/kg may be used only when all of the following conditions are met:

Under no circumstances should clinicians resume lamotrigine at the previously tolerated dose after a gap exceeding 5 days; doing so bypasses the safety‑critical titration process and markedly increases the likelihood of severe cutaneous reactions. 5